[1] Ginestier C, Hur MH, Charafe-Jauffret E, et al.ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome[J].Cell Stem Cell, 2007, 1(5):555-567.
[2] Levi BP, Yilmaz OH, Duester G, et al. Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems[J].Blood, 2009, 113(8):1670-1680.
[3] Hess DA, Wirthlin L, Craft TP, etal. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells[J]. Blood, 2006, 107(5):2162-2169.
[4] Cheung AM, Wan TS, Leung JC, et al. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential[J].Leukemia, 2007,21(7):1423-1430.
[5] Tomita H, Tanaka K, Tanaka T,et al. Aldehyde dehydrogenase 1A1 in stem cells and cancer[J].Oncotarget, 2016,7(10):11018-11032.
[6] Yanagawa Y, Chen JC, Hsu LC, et al. The transcriptional regulation of human aldehyde dehydrogenaseⅠ gene. The structural and functional analysis of the promoter[J].J Biol Chem, 1995, 270(29):17521-17527.
[7] Deng S, Yang X, Lassus H, et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1(ALDH1), in human epithelial cancers[J]. PLoS One, 2010, 5(4):e10277.
[8] Kastan MB,Schlaffer E,Russo JE,etal.Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells[J]. Blood, 1990,75(10):1947-1950.
[9] Jones RJ, Collector MI, Barber JP, et al.Characterization of mouse lymphohematopoietic stem cells lacking spleencolony-forming activity[J]. Blood, 1996, 88(2):487-491.
[10] Chute JP, Muramoto GG, Whitesides J, et al.Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells[J]. Proc Natl Acad Sci U S A, 2006, 103(31):11707-11712.
[11] Corti S, Locatelli F, Papadimitriou D,etal.Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity[J].Stem Cells, 2006,24(4):975-985.
[12] Liu SY, Zheng PS. High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer[J]. Oncotarget, 2013, 4(12):2462-2475.
[13] Chen YC, Chen YW, Hsu HS, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer[J]. Biochem Biophys Res Commun, 2009, 385(3):307-313.
[14] Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer[J]. Mol Cancer Res, 2009, 7(3):330-338.
[15] Kim H, Lapointe J, Kaygusuz G,et al.The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer[J]. Cancer Res,2005,65(18):8118-8124.
[16] Li C, Heidt DG, Dalerba P, et al.Identification of pancreatic cancer stem cells[J].Cancer Res, 2007, 67(3):1030-1037.
[17] Seigel GM, Campbell LM, Narayan M, et al. Cancer stem cell characteristics in retinoblastoma[J]. Mol Vis, 2005, 11:729-737.
[18] Pearce DJ, Taussig D, Simpson C, et al. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples[J]. Stem Cells, 2005, 23(6):752-760.
[19] Dylla SJ, Beviglia L, Park IK, et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy[J]. PLoS One, 2008, 3(6):e2428.
[20] Huang EH, Hynes MJ, Zhang T, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis[J]. Cancer Res, 2009, 69(8):3382-3389.
[21] Kuroda T, Hirohashi Y, Torigoe T, et al. ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis[J]. PLoS One, 2013, 8(6):e65158.
[22] Rao QX, Yao TT, Zhang BZ, et al. Expression and functional role of ALDH1 in cervical carcinoma cells[J]. Asian Pac J Cancer Prev, 2012, 13(4):1325-1331.
[23] Kohn FR,Sladek NE. Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines[J]. Biochem Pharmacol, 1985, 34(19):3465-3471.
[24] Magni M,Shammah S, Schiró R, et al. Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer[J]. Blood, 1996, 87(3):1097-1103.
[25] Moreb JS,Gabr A.Retinoic acid down-regulates aldehyde dehydrogenaseand increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde[J].Pharmacol Exp Ther,2005,312(1):339-345.
[26] Honoki K, Fujii H, Kubo A, et al. Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance[J]. Oncol Rep, 2010, 24(2):501-505.
[27] 冯敏清,周晖,彭永排,等. 耐放疗宫颈癌Caski细胞ALDH-1表达的研究[J].临床和实验医学杂志,2012,11(7):526-529.
[28] Chen J, Xia Q, Jiang B, etal. Prognostic value of cancer stem cell marker ALDH1 expression in colorectal cancer:A Systematic Review and Meta-Analysis[J].PLoS One, 2015, 10(12):e0145164.
[29] Huo W, Du M, Pan XY, et al. Prognostic value of ALDH1 expression in lung cancer:a meta-analysis[J]. Int J Clin Exp Med, 2015, 8(2):2045-2051.
[30] Yao TT, Chen Q, Zhang BZ,et al. The expression of ALDH1 in cervical carcinoma[J]. Med Sci Monit, 2011, 17(8):HY21-26.
[31] Lin J, Liu X, Ding D, et al. Evidence for epithelial-mesenchymal transition in cancer stem-like cells derived from carcinoma cell lines of the cervix uteri[J]. Int J Clin Exp Pathol, 2015, 8(1):847-855.